Form 4: Marimed Director Receives Equity Compensation

Marimed Inc. Director David R. Allen was granted 176,389 Restricted Stock Units as compensation for his board service, vesting on December 15, 2025.

Summary

• David R. Allen, a Director of Marimed Inc. (MRMD), reported a change in beneficial ownership.
• Allen was granted 176,389 Restricted Stock Units (RSUs) on December 5, 2025.
• These RSUs convert to shares of common stock on a one-for-one basis.
• The RSUs were granted in lieu of cash payment for a portion of Allen's fees for serving on the Issuer's Board of Directors.
• The RSUs are scheduled to vest in full on December 15, 2025.
• Following this transaction, Allen beneficially owns 299,755 shares of common stock directly and 176,389 derivative securities (RSUs) directly.

Sentiment

Score: 6

Explanation: Slightly positive due to increased alignment of director's interests with shareholders through equity compensation, which is a standard and expected practice.

Positives

• The grant of Restricted Stock Units (RSUs) to Director David R. Allen aligns his interests with those of shareholders, as his compensation is tied to the company's stock performance.
• Utilizing equity compensation instead of cash can help conserve the company's cash reserves.

Negatives

• The issuance of new equity, even as RSUs, can lead to minor dilution for existing shareholders upon vesting and conversion to common stock.

Risks

• The value of the RSU compensation is directly tied to the future market price of Marimed Inc. common stock, exposing the director to market volatility.
• Potential for minor stock dilution upon the vesting and conversion of the RSUs into common stock.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedule of the granted Restricted Stock Units.

Industry Context

Equity compensation, particularly Restricted Stock Units (RSUs), is a common practice across various industries, including the cannabis sector where Marimed operates, to attract and retain talent, and align management interests with shareholder value. This type of compensation is standard for board members.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as compensation for board service is a widely accepted practice in corporate governance, aligning director incentives with long-term company performance.
• Many publicly traded companies, including peers in the cannabis industry, utilize similar equity-based compensation structures for their directors and executives to conserve cash and promote shareholder alignment.
• For example, companies like Curaleaf Holdings, Green Thumb Industries, and Trulieve Cannabis Corp. frequently disclose equity grants to their leadership as part of their compensation packages, reflecting a common industry standard.

Related Party Transactions

• The grant of 176,389 Restricted Stock Units to Director David R. Allen as compensation for his board service constitutes a related party transaction, as it involves a transaction between the company and a member of its board of directors.

Stakeholder Impact

• Shareholders: Increased alignment of Director David R. Allen's interests with shareholders due to equity-based compensation. Potential for minor dilution upon RSU vesting and conversion.
• Management/Directors: David R. Allen receives compensation for his board service in the form of equity, linking his financial incentives directly to the company's stock performance.

Next Steps

• The 176,389 Restricted Stock Units (RSUs) are scheduled to vest in full on December 15, 2025.
• Upon vesting, these RSUs will convert into shares of Marimed Inc. common stock on a one-for-one basis.

Key Dates

Keywords

Marimed Inc., MRMD, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Compensation, Director Compensation, Beneficial Ownership